# Dynamic modulation of N6-methyladenosine by ionizing radiation in human cells

**Authors:** L. Cruz-Garcia, Philip Davies, Veronika Goriacha, Mustafa Najim, Stanislav Polozov, Maria Polozova, Christophe Badie

PMC · DOI: 10.1016/j.bbrep.2026.102528 · Biochemistry and Biophysics Reports · 2026-03-02

## TL;DR

This study shows that ionizing radiation rapidly and dynamically changes RNA methylation in human cells, with potential implications for cancer treatment and radiation protection.

## Contribution

The study reveals a dynamic, time-dependent modulation of m6A RNA methylation in response to ionizing radiation in human cells.

## Key findings

- m6A methylation peaks one minute after radiation exposure and then fluctuates over time.
- Two UQCR10 transcripts show stable hypermethylation following radiation exposure.
- Disruption of m6A enzymes reduces RNA methylation in response to radiation.

## Abstract

A cell's transcriptome is regulated through the integration of external and internal signals that activate intracellular signal pathways, epigenetic modifications and post-translational changes. Post-transcriptional regulation through RNA methylation has emerged as an important mechanism in cancer development, and informative for diagnosis and treatment. The most abundant one, N6-methyladenosine (m6A), regulates gene expression in eukaryotes. In the present study m6A RNA modifications have been characterized in response to ionizing radiation (IR) exposure in the HT1080 human cell line. Cells were exposed to a dose of 10 Gy of X-rays and harvested 1, 2, 10 min, 1 and 24 h after exposure. m6A sites were identified using long read nanopore direct RNA sequencing. A pipeline was designed using m6Anet to estimate m6A stoichiometries transcriptome-wide, which were then analysed by a beta-binomial regression model with moderated dispersion estimates and independent filtering to detect differentially methylated (DM) sites between treated and control samples. We found that IR modifies m6A sites in a dynamic way, inducing site specific increase of methylation. Remarkably, it peaks within the first minute after exposure, followed by a sharp decrease at 1 h without returning to baseline, increasing again after 24 h. Two transcripts of the nuclear encoded gene UQCR10, a subunit of the respiratory chain protein, sharing the same site presented a stable hypermethylation over time, confirmed by a modified quantitative PCR assay. Moreover, we generated Knockouts (KO) cell lines for 3 key enzymes involved in m6A methylation, a writer, a reader and an eraser namely METTL3, YTHDF2 and FTO, to better understand mechanistically IR driven m6A dynamics. Importantly, all three KOs presented a transcriptome wide decrease in RNA methylation following IR exposure. Lastly, m6A modifications were also confirmed in human skin biopsies exposed to IR, with the UQCR10 gene site also hypermethylated 24 h after a lower 2 Gy X-rays dose. To summarise, we provide evidence that IR modulates RNA m6A levels in a site-specific and dynamic way, with DM sites enriched in genes involved in bioenergetics, cell signalling/migration and apoptosis pathways, thus representing a rapid cellular response to radiation. Considering the essential role of m6A in controlling gene expression and physiological activities, this study established the basis for further studies assessing IR driving m6A with a potential role in radiation oncology and protection.

•IR dynamically modifies m6A sites, causing site-specific increases in methylation.•m6A methylation peaks at 1 min, drops at 1 h, then rises again by 24 h post-exposure.•Two UQCR10 transcripts sharing a site showed stable hypermethylation over time.•DM sites are enriched in genes of bioenergetic, signaling, apoptotic pathways.•IR-mediated RNA methylation responses require functional writers, readers and erasers.

IR dynamically modifies m6A sites, causing site-specific increases in methylation.

m6A methylation peaks at 1 min, drops at 1 h, then rises again by 24 h post-exposure.

Two UQCR10 transcripts sharing a site showed stable hypermethylation over time.

DM sites are enriched in genes of bioenergetic, signaling, apoptotic pathways.

IR-mediated RNA methylation responses require functional writers, readers and erasers.

## Linked entities

- **Genes:** UQCR10 (ubiquinol-cytochrome c reductase, complex III subunit X) [NCBI Gene 29796], METTL3 (methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit) [NCBI Gene 56339], YTHDF2 (YTH N6-methyladenosine RNA binding protein F2) [NCBI Gene 51441], FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068]
- **Proteins:** UQCR10 (ubiquinol-cytochrome c reductase, complex III subunit X)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068] {aka ALKBH9, BMIQ14, GDFD, IFEX9}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, SUGCT (succinyl-CoA:glutarate-CoA transferase) [NCBI Gene 79783] {aka C7orf10, DERP13, GA3, ORF19}, YTHDF2 (YTH N6-methyladenosine RNA binding protein F2) [NCBI Gene 51441] {aka CAHL, DF2, HGRG8, NY-REN-2}, UQCR10 (ubiquinol-cytochrome c reductase, complex III subunit X) [NCBI Gene 29796] {aka HSPC051, HSPC119, HSPC151, QCR9, UCCR7.2, UCRC}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, BTG2 (BTG anti-proliferation factor 2) [NCBI Gene 7832] {aka APRO1, PC3, TIS21}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, ALKBH5 (alkB homolog 5, RNA demethylase) [NCBI Gene 54890] {aka ABH5, OFOXD, OFOXD1}, NCOA4 (nuclear receptor coactivator 4) [NCBI Gene 8031] {aka ARA70, ELE1, PTC3, RFG}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, METTL3 (methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit) [NCBI Gene 56339] {aka IME4, M6A, MT-A70, Spo8, hMETTL3}, P4HB (prolyl 4-hydroxylase subunit beta) [NCBI Gene 5034] {aka CLCRP1, DSI, ERBA2L, GIT, P4Hbeta, PDI}, FDXR (ferredoxin reductase) [NCBI Gene 2232] {aka ADR, ADXR, ANOA, MMDS9B}
- **Diseases:** DM (MESH:D012734), lung squamous cell carcinoma (MESH:D002294), IR (MESH:D011832), liver cancer (MESH:D006528), neuroblastoma (MESH:D009447), leukemia (MESH:D007938), inflammation (MESH:D007249), toxicity (MESH:D064420), fibrosarcoma (MESH:D005354), cancer (MESH:D009369)
- **Chemicals:** 5-methyluridine (MESH:C009182), m6A (MESH:C005955), H2O (MESH:D014867), SYBR Green (MESH:C098022), CO2 (MESH:D002245), ROS (MESH:D017382), poly(A) (MESH:D011061), 5-methylcytidine (MESH:C016568), PBS (MESH:D007854), PVDF (MESH:C024865), adenines (MESH:D000225), penicillin (MESH:D010406), adenosine (MESH:D000241), 1-methylguanosine (MESH:C020770), N6-methyladenosine (MESH:C010223), hydrogen peroxide (MESH:D006861), DM (-), 3-methyluridine (MESH:C008513), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), 1-methyladenosine (MESH:C002230)
- **Species:** Mycoplasma (genus) [taxon 2093], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), MOLM13 — Homo sapiens (Human), Adult acute monocytic leukemia, Cancer cell line (CVCL_2119), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), HT-1080 — Homo sapiens (Human), Fibrosarcoma, Cancer cell line (CVCL_0317), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), U2Os — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_1697), R9 — Rattus norvegicus (Rat), Transformed cell line (CVCL_4282), CCL-121 — Mus musculus (Mouse), Undefined cell line type (CVCL_M023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969311/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12969311/full.md

## References

110 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969311/full.md

---
Source: https://tomesphere.com/paper/PMC12969311